Nutriband Inc NTRB

$6.29 -0.12 (-1.87%)

Valuation

Market cap
77,920,000
Revenue TTM
$2,040,000
Net income TTM
$-8,230,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-403.43%
Debt to equity
0.01

Trading

Volume
17,800
Avg volume
80,506
Day's range
$6.01 – $6.51
Shares out
12,156,000
Stochastic %K
62%
Beta
2.17
Analysts
Strong Buy
Price target
$15.00

Price

Company profile

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in...

Show more

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Industry
Biotechnology
Sector
Healthcare
Phone
407 377 6695
Website
https://www.nutriband.com
Address
121 South Orange Avenue, Suite 1500, Orlando, United States

Latest news

Stocktwits

Channelchek Nov 2, 2:30 PM
Noble Capital Markets Research Report: Nutriband ($NTRB) – Progress Reported Toward Start Of Clinical Trial Commercial Preparations Continue. Nutriband continues to prepare for the AVERSA Fentanyl clinical trial, now expected to begin in 1H27. The NDA will be submitted through the 505(b)(2) pathway and requires a single Phase 1 trial demonstrating abuse deterrence with AVERSA Fentanyl technology. Read full report here: https://www.channelchek.com/news-channel/nutriband-ntrb-progress-reported-toward-start-of-clinical-trial
0 replies
BullInvest Oct 29, 6:15 PM
$NTRB I can sense that the time is coming…
0 replies
birdmanCap Oct 28, 2:44 PM
$NTRB ok so looks like we have a base at $6 Not bad at all dude!
0 replies
FlashAim Oct 27, 7:38 PM
$MBOT $KITT $NTRB |Lambo|2
0 replies
RolandRickPerry Oct 20, 7:55 PM
$NTRB Quiet Before the Storm? Nutriband Pulls Back. Report on upcoming cinical trial coming. https://internetstockreview.com/quiet-before-the-storm-nutriband-pulls-back/
0 replies
BarryJets Oct 18, 4:39 PM
$NTRB Company-estimated peak US annual sales of $80M–$200M for AVERSA Fentanyl.^*
0 replies
birdmanCap Oct 16, 2:01 PM
$NTRB nice consolidation
0 replies
lastpenny101 Oct 13, 6:21 PM
$NTRB https://finance.yahoo.com/healthcare/articles/nutriband-inc-announces-exercise-warrants-120000012.html
0 replies